Antibody Drug Conjugates Market is Anticipated to Witness High Growth Owing to Robust R&D Investment and Stringent Regulatory Guidelines
Antibody drug conjugates (ADCs) are a type of chemotherapeutic drug that uses the specificity of monoclonal antibodies to deliver highly potent antitumor payloads directly to cancer cells while limiting exposure to healthy tissue. ADCs employ sophisticated chemistry to attach highly potent cancer fighting drugs to antibodies that bind selectively to tumor cells. This allows ADCs to deliver...
0 Comments 0 Shares 319 Views 0 Reviews
Sponsored